Emerging roles of m6A RNA modification in cancer therapeutic resistance

Marvelous advancements have been made in cancer therapies to improve clinical outcomes over the years. However, therapeutic resistance has always been a major difficulty in cancer therapy, with extremely complicated mechanisms remain elusive. N6-methyladenosine (m6A) RNA modification, a hotspot in e...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei-Wei, Zhang, Zhong-Yuan, Wang, Fei, Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942381/
https://www.ncbi.nlm.nih.gov/pubmed/36810281
http://dx.doi.org/10.1186/s40164-023-00386-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942381/
https://www.ncbi.nlm.nih.gov/pubmed/36810281
http://dx.doi.org/10.1186/s40164-023-00386-2

Ejemplares similares